Proof-of-concept trial of ATI-50001 [A-201] in healthy volunteers.

Trial Profile

Proof-of-concept trial of ATI-50001 [A-201] in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs ATI 50001 (Primary)
  • Indications Alopecia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Proof of concept
  • Sponsors Aclaris Therapeutics
  • Most Recent Events

    • 15 Mar 2017 Status changed from recruiting to completed, according to an Aclaris Therapeutics media release.
    • 07 Dec 2016 According to Aclaris Therapeutics media release, company has initiated dosing of patients in this pharmacokinetic/pharmacodynamic (PK/PD) trial.
    • 07 Dec 2016 Status changed from planning to recruiting, according to Aclaris Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top